Nov 22 (Reuters) - Inventiva SA IVAA.PA :
* INVENTIVA REPORTS 2023 THIRD QUARTER FINANCIAL INFORMATION
* ESTIMATED CASH RUNWAY EXPECTED TO BE EXTENDED TO BEGINNING
OF Q3
2024
* 9M REVENUE EUR 1.9 MLN VS EUR 0.1 MLN YR AGO
* CASH AND CASH EQUIVALENTS AT EUR 43.8 MLN AT END-SEPT VS
EUR
86.7 MLN YR AGO
* DECREASE IN CASH "MAINLY DUE TO INCREASED CASH USED IN
OPERATING
ACTIVITIES AND REFLECTS THE 2023 PLANNED AND CONTINUED
ACCELERATION OF CLINICAL DEVELOPMENT ACTIVITIES"
* EXPECTS TO MEET FINANCIAL CONDITIONS FOR THE DISBURSEMENT
OF THE
SECOND TRANCHE OF EUR 25 MLN OF THE LOAN GRANTED BY THE EIB BY
END 2023 IF IT RECEIVES THE ANTICIPATED $3 MLN MILESTONE PAYMENT
FROM SINO BIOPHARM
Source text for Eikon: ID:nGNX4BBjpT
Further company coverage: IVAA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))